# US 2010/0166785 A1 · Adjuvants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0166785 A1
- Document ID: US20100166785A1
- Status: Published application
- Kind: A1
- Application number: 12/702,567
- Filed: 2010-02-09
- Published: 2010-07-01
- Earliest claimed: 2007-12-07
- Assignees: National Health Research Institutes
- Inventors: Shih-Jen Liu; Hsueh-Hung Liu; Chih-Hsiang Leng; Hsin-Wei Chen; Yan Chak Kwok; Pele Choi-Sing Chong
- Web page: https://patentgrep.com/patent/US20100166785A1

## CPC

- C07K 14/195: from bacteria
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 35/00: Antineoplastic agents
- A61P 37/04: Immunostimulants
- C07K 14/22: from Neisseriaceae (F)
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

Disclosed are lipopeptides or lipoproteins, related compositions, and related methods.

## Claims

### Claim 1

An isolated lipopeptide or lipoprotein having the structure of formula (I):
wherein
one of R1, R2, and R3 is C14-20 alkenyl, and each of the others, independently is C14-20 alkyl or C14-20 alkenyl; and
X is an amino acid sequence that is 1-100 amino acid residues in length.

### Claim 2 (depends on 1)

The lipopeptide or lipoprotein of claim 1, wherein R2 is C14-20 alkenyl.

### Claim 3 (depends on 2)

The lipopeptide or lipoprotein of claim 2, wherein each of R1 and R3 is C14-20 alkyl.

### Claim 4 (depends on 2)

The lipopeptide or lipoprotein of claim 2, wherein R2 is —(CH2)7—CH═CH—(CH2)5CH3.

### Claim 5 (depends on 4)

The lipopeptide or lipoprotein of claim 4, wherein each of R1 and R3 is C14-20 alkyl.

### Claim 6 (depends on 5)

The lipopeptide or lipoprotein of claim 5, wherein each of R1 and R3 is —(CH2)14CH3.

### Claim 7 (depends on 6)

The lipopeptide or lipoprotein of claim 6, the N-terminus of X is linked to the carbonyl group adjacent to X shown in formula (I).

### Claim 8 (depends on 1)

The lipopeptide or lipoprotein of claim 1, wherein the lipopeptide or lipoprotein has the following configuration:

### Claim 9 (depends on 1)

The lipopeptide or lipoprotein of claim 1, wherein the lipopeptide is

### Claim 10 (depends on 1)

The lipopeptide or lipoprotein of claim 1, wherein X has the sequence of SEQ ID NO: 7 or 8.

### Claim 11 (depends on 1)

The lipopeptide or lipoprotein of claim 1, wherein X is 3-20 amino acid residues in length.

### Claim 12 (depends on 1)

The lipopeptide or lipoprotein of claim 1, wherein one of R1, R2, and R3 is C14-20 alkenyl, and each of the others, independently is C16-20 alkyl or C16-20 alkenyl.

### Claim 13 (depends on 12)

The lipopeptide or lipoprotein of claim 12, wherein one of R2 or R3 is C14-20 alkenyl, and R1 is C16 alkyl.

### Claim 14 (depends on 1)

An adjuvant composition comprising an isolated lipopeptide or lipoprotein of claim 1.

### Claim 15 (depends on 1)

An immunogenic composition comprising an antigen and an isolated lipopeptide or lipoprotein of claim 1.

### Claim 16 (depends on 1)

A method of inducing an immunological response in a subject comprising administering to a subject in need thereof an antigen and an isolated lipopeptide or lipoprotein of claim 1.

### Claim 17 (depends on 1)

A method of preparing a lipopeptide or lipoprotein of claim 1, comprising:
providing a host E. coli cell containing a nucleic acid encoding a protein that has a first segment having a lipidating sequence that includes the sequence of SEQ ID NO: 3;
cultivating the E. coli cell in a medium under condition permitting expression of the protein in lipidated form; and
purifying the lipidated form of the protein from the cell or the medium.

### Claim 18 (depends on 17)

The method of claim 17, further comprising incubating the lipidated form of the protein with a protease to generate the lipopeptide.

### Claim 19 (depends on 17)

The method of claim 17, wherein the nucleic acid is heterologous to the cell.

### Claim 20 (depends on 17)

The method of claim 17, wherein the lipidating sequence includes the sequence of SEQ ID NO: 1, 6, 7, 8, or 9.
